Bigger May Be Better for Health Insurers, but Doubts Remain for Consumers

Deals among the nation’s largest health insurers in recent weeks have been almost head-spinning. But whatever the details, if the combinations are finalized, the result will be an industry dominated by three colossal insurers. Consumer advocates, policy experts and former regulators say that what may be good for the insurers may not be good for […]

Groundless Fears About Medicaid and Medicare

The 50th anniversary of Medicare and Medicaid should be an occasion for celebrating public programs that have made a positive difference in the lives of millions of Americans and a reminder of the critical need to preserve their legacies. It’s easy to forget that our country once allowed half of its seniors and the vast […]

Drug Prices Soar, Prompting Calls for Justification

As complaints grow about exorbitant drug prices, pharmaceutical companies are coming under pressure to disclose the development costs and profits of those medicines and the rationale for charging what they do. So-called pharmaceutical cost transparency bills have been introduced in at least six state legislatures in the last year, aiming to make drug companies justify […]